Unmasking the expression of PD-L1 in Myeloid Derived Suppressor Cells: A case study in lung cancer to discover new drugs with specific on-target efficacy.

IF 4.5 2区医学 Q1 ONCOLOGY

Translational Oncology Pub Date : 2021-01-01 Epub Date: 2020-12-07 DOI:10.1016/j.tranon.2020.100969

Laura G Rico, Andrés Aguilar Hernández, Michael D Ward, Jolene A Bradford, Jordi Juncà, Rafael Rosell, Jordi Petriz

引用次数: 3

Abstract Image

查看原文本刊更多论文

揭示髓系来源抑制细胞中PD-L1的表达:肺癌的一个案例研究，以发现具有特异性靶向疗效的新药。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Translational Oncology Biochemistry, Genetics and Molecular Biology-Cancer Research

CiteScore

7.20

自引率

2.00%

发文量

314

审稿时长

6-12 weeks

期刊介绍： Translational Oncology publishes the results of novel research investigations which bridge the laboratory and clinical settings including risk assessment, cellular and molecular characterization, prevention, detection, diagnosis and treatment of human cancers with the overall goal of improving the clinical care of oncology patients. Translational Oncology will publish laboratory studies of novel therapeutic interventions as well as clinical trials which evaluate new treatment paradigms for cancer. Peer reviewed manuscript types include Original Reports, Reviews and Editorials.